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Chapter One 
 
Literature Review 
 
Liver Function and Structure 
 The function and structure of the liver are well understood.  The following information on 
the function and structure of the liver is adapted from Casarett and Doull’s Toxicology: The Basic Science 
of Poisons (Klaassen, 2008), and Wheater’s Functional Histology: A Text and Colour Atlas (Young, 2006). 
 
Liver Function:  The liver resides within the upper abdominal quadrant between the intestinal tract 
and the rest of the body.  It is responsible for numerous functions including metabolism, synthesis 
and secretion of bile and cholesterol, synthesis of plasma proteins, and detoxification and excretion 
into bile of endogenous waste products and xenobiotics.  The liver is one of the first organs to come 
into direct contact with orally ingested nutrients, xenobiotics, and toxicants via blood entering the 
organ through the portal vein from the intestine, and is therefore, critically important in xenobiotic 
transformation, converting hydrophobic substances into water-soluble derivatives that can be 
excreted into bile and urine. 
 
Liver Structure:  The liver represents approximately 2.5% of total body weight and contains various 
cell types including hepatocytes (parenchymal cells), sinusoidal lining cells (Kupffer, Ito, endothelial), 
hematopoietic cells, nerve cells, lymphatic cells, and blood vessel cells. 
 Hepatocytes represent 60-80% of the entire cell population within the liver.  These cells are 
large polyhedral cells with round nuclei with peripherally dispersed chromatin.  The nuclei can vary 
greatly in size and binucleated hepatocytes are common in normal liver. 
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 Endothelial lining cells are readily distinguishable from hepatocytes by their flattened 
condensed nuclei.  These cells lack a basement membrane and allow for the exchange of fluids and 
nutrients between hepatocytes and the sinusoid.  Kupffer cells are resident macrophages of the liver 
that phagocytize particles, secrete mediators of inflammation, detoxify endotoxins, process antigens, 
and catabolize lipids and glycoproteins.  Finally, Ito cells are fat-storing cells that serve as a major 
storage site for vitamin A. 
 The hepatic lobule is the structural unit of the liver, defined according to structural and 
functional differences.  The hepatic lobule is hexagonal in shape and is centered on a terminal 
hepatic venule or centrilobular venule.  Portal tracts (triads) are positioned at the angles of the 
hexagon.  The portal triads contain branches for the portal vein, hepatic arteriole, and bile duct.  
Blood flows away from the branches of the portal vein and hepatic arteriole toward the adjacent 
central veins. 
 The hepatic lobule is divided into three zones.  Zone 1 is the periportal zone.  This zone is 
closest to the portal tract and because hepatocytes in this zone are closest to afferent vessels, this 
zone receives the most oxygenated blood.  Zone 2 is the midzonal region.  Zone 3 is the 
centrilobular zone and has low levels of oxygenated blood.  Gradients of proteins involved in 
bioactivation, detoxification, and transportation of xenobiotics have been observed along these three 
zones.  For example, levels of glutathione (GSH), fatty acid oxidation, and gluconeogenesis are 
highest in zone 1, but cytochrome P450, essential for drug metabolism, enzyme levels are highest 
around the centrilobular venule. 
 
Nrf2 Signaling Pathway 
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively 
regulates the expression and activity of cytoprotective genes during periods of oxidative stress.  Nrf2 
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was originally identified during a screening process for proteins that bind to the locus control region 
(LCR) of the β-globin gene cluster (Moi, 1994).  The β-globin gene cluster consists of five genes on 
chromosome 11 which are responsible for the creation of the beta components of hemoglobin.  
Within the LCR, there are four DNAse I hypersensitive sites that serve as binding sites for the 
transcription factors AP1 (activation protein 1), GATA-1 (an erythroid specific transcription factor), 
and NF-E2 (nuclear factor erythroid 2).  It was during this screening process that a binding protein, 
given the name Nrf2, was identified and was shown to exhibit remarkable similarity to NF-E2. 
Nrf2 was found to bind the same hypersensitive sites as NF-E2 within the LCR of the β-
globin gene cluster.  Furthermore, both are RNA polymerase activators and belong to the cap ‘n’ 
collar family of transcription factors, members of which share a conserved basic leucine zipper 
structure (Moi, 1994).  However, unlike NF-E2 which is predominately expressed in erythroid cells, 
Nrf2 was found to be ubiquitously expressed in all cell types, most predominantly in the kidney, 
muscle, lung, heart, liver, and brain (Andrews, 1993, Chan, 1996, Itoh, 1995, McMahon. 2001, Moi, 
1994). 
 
Negative Regulation of Nrf2 
Under basal conditions, Kelch-like ECH-associated protein 1 (Keap1) is a negative regulator 
of Nrf2, responsible for the binding and inactivation of Nrf2 in the cytoplasm (Itoh, 1999, Kang, 
2004).  The double glycine repeat (DGR) region of Keap1 binds the Nrf2-ECH homology 2 (Neh2) 
domain in the N-terminus region of Nrf2, thereby sequestering Nrf2 in the cytosol and repressing 
its activity (Itoh, 1999).  The BTB (broad complex, tramtrack, bric-a-brac) domain of Keap1 binds 
Cullin-3 of the Cullin3/Ring Box 1 (Cul3/Rbx1) E3 ubiquitin ligase complex which is responsible 
for the recruitment of ubiquitin-conjugating enzymes that in turn, label Nrf2 for proteosomal 
degradation.  Consequently, under normal cellular conditions, the cytosolic Keap1/Cul3-Rbx1 
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complex is constantly degrading Nrf2.  However, in the presence of oxidative stress, Nrf2 
dissociates from Keap1 and translocates into the nucleus of the cell leading to the activation of 
antioxidant response element (ARE)-mediated gene transcription. 
A number of plausible mechanisms for the dissociation of Nrf2 from Keap1 have been 
suggested.  Phosphorylation of a serine residue at position 40 on Nrf2 in response to electrophilic or 
oxidative stress has been shown to result in the release of Nrf2 from Keap1 (Bloom, 2003).  There 
are also three cysteine residues on Keap1 crucial for its activity including Cys151, Cys273, and 
Cys288.  Research has shown that modification of Cys151 leads to a change in the conformation of 
the BTB domain of Keap1, causing a switch of ubiquitination of Nrf2 to Keap1, which is thought to 
lead to Nrf2 nuclear accumulation (Zhang, 2003).  Mutations of a serine residue at position 104 on 
Keap1 have also been shown to disrupt Keap1 dimerization, leading to the release of Nrf2 (Zipper, 
2002).  Furthermore, de-phosphorylation of a tyrosine residue at position 141 on Keap1 causes 
destabilization and degradation of the cytosolic protein leading to the release of Nrf2 (Jain, 2008).  It 
remains uncertain, however, whether the above mechanisms work in concert with one another or 
are independent in their ability to cause the dissociation of Nrf2 from Keap1. 
 
Nrf2-Mediated Transcription 
 Once inside the nucleus, Nrf2 heterodimerizes with transcriptional regulatory proteins such 
as Maf or Jun proteins (Aleksunes, 2007).  These Nrf2 partners are often members of the activator 
protein-1 (AP-1) family of proteins (Itoh, 1997, Wild, 1999).  These heterodimeric complexes are 
then able to bind ARE sequences in the promoter regions of genes involved in cytoprotection.  The 
functional ARE sequence contains a common core 5’-GTGACnnnGC-3’ motif, where ‘n’ represents 
any nucleotide (Rushmore, 1991).  Jun, for example, has been shown to interact with Nrf2 and 
 5 
 
overexpression of both Jun and Nrf2 in hepatoma cells activates ARE-mediated transcription 
(Venugopal, 1998). 
 
Nrf2-Responsive Genes 
 ARE-containing genes identified as targets of Nrf2 are involved in a variety of cellular 
functions including xenobiotic metabolism, reactive oxygen species scavenging, GSH homeostatsis, 
and xenobiotic efflux transport pathways (Nguyen, 2003).  These genes include, among others, 
NAD(P)H quinone oxidoreductase 1 (Nqo1), heme oxygenase 1 (Ho-1), multidrug resistance-
associated protein transporters (Mrp1-4), glutamate cysteine ligase catalytic subunit (Gclc), and 
glutamate cysteine ligase modifier subunit (Gclm) (Aleksunes, 2007).  An impaired expression of 
these genes can increase the sensitivity of cells to oxidative damage. 
 
NAD(P)H Quinone Oxidoreductase 1:  NAD(P)H quinone oxidoreductase 1 (Nqo1) is a detoxification 
enzyme that reduces reactive quinones and quinone-imines to less reactive and less toxic 
hydroquinones (Siegel, 2004).  Early studies identified an ARE sequence in the mouse and rat Nqo1 
promoter region (Rushmore, 1991).  Additionally, chemical treatment with the Nrf2 activator 
butylated hydroxyanisole (BHA) increases hepatic and intestinal Nqo1 expression levels in wild-type, 
but not Nrf2-null, mice (Ishii, 2002), confirming a regulatory role for Nrf2 in the expression of 
Nqo1. 
 
Heme Oxygenase-1:  Heme oxygenase-1 (Ho-1) catabolizes prooxidant heme to carbon monoxide, 
biliverdin, and free iron.  Its name is synonymous with heat shock protein 32.  Ho-1 is a hallmark 
target of Nrf2 (Alam, 1999) and is commonly up-regulated following oxidative stress and cellular 
injury (Guo, 2001).  Unlike Nqo1, traditionally considered a drug metabolizing enzyme, Ho-1 is 
more often thought of as a stress-inducible gene. 
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Multidrug Resistance-Associated Protein Transporters:  In addition to the detoxification of chemicals as a 
means for ameliorating cellular injury, plasma membrane efflux transport proteins can eliminate 
chemicals from within the cell, thereby minimizing cellular stress and injury.  Literature suggests that 
ATP-dependent efflux transporters including multidrug resistance-associated proteins (Mrps) may 
be involved in the antioxidant response (Klaassen, 2005).  Mrps belong to the ATP-binding cassette, 
subfamily c (Abcc).  ARE sequences have been identified in the mouse Mrp1 (Hayashi, 2003) and 
Mrp2 (Vollrath, 2006) promoters.  Furthermore, treatment of mice with Nrf2 activating chemicals 
shows induction of Mrps in wild-type mice (Maher, 2005, Aleksunes, 2008), but not in Nrf2-null 
mice (Aleksunes, 2008), confirming the role of these transporter proteins in the Nrf2 response 
pathway. 
 
Glutamate Cysteine Ligase:  Glutamate cysteine ligase (Gcl), also known as γ-glutamyl cysteine 
synthetase, catalyzes the formation of γ-glutamylcysteine, the rate-limiting step in GSH synthesis, 
from glutamine and cysteine in the presence of ATP.  Glutathione (GSH) plays an important role in 
intracellular redox balance and protecting against cellular oxidative stress through the detoxification 
of chemicals by directly binding or enzymatic conjugation.  Gcl is comprised of a catalytic (Gclc) 
subunit and modifier (Gclm) subunit, both of which contain ARE sequences in their promoter 
regions (Seelig, 1984, Mulcahy, 1997).  The catalytic subunit composes the heavy chain portion of 
Gcl while the modifier subunit is known to increase the efficiency of the catalytic subunit.  Livers 
from Nrf2-null mice show diminished gene expression of both Gclc and Gclm as well as lower GSH 
stores when compared to wild-type counterparts (Chan, 2000, Chanas, 2002).  The regulation of 
Gclc and Gclm by Nrf2 highlights the critical role this nuclear transcription factor undertakes in 
maintaining cellular GSH homeostasis. 
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Acetaminophen (APAP) Hepatotoxicity 
Incidence:  Acetaminophen (APAP) is a commonly used analgesic and antipyretic.  APAP is also one 
of the leading causes of acute liver failure (ALF) in the United States (Reuben, 2010).  Since the early 
2000’s, APAP has been attributed to approximately 50% of all acute liver failure cases across the 
United States (Reuben, 2010).  To address this concern, in January 2011, the United States Food and 
Drug Administration recommended to manufacturers of prescription combination drug products 
containing acetaminophen to limit the amount of acetaminophen to no more than 325 milligrams 
per tablet or capsule (U.S. Food and Drug Administration, 2011). 
Currently, N-Acetyl cysteine (NAC), a precursor to GSH, is the only standard therapy used 
to prevent and decrease APAP-induced hepatotoxicity.  However, this treatment is administered 
only in a hospital setting and must be administered within 8 hours following overdose to be most 
effective (Algren, 2008).  In the case of accidental overdose, however, ALF may not be evident 
within 8 hours, at which point administration of NAC is no longer beneficial (Larson, 2005).  It is 
clear from these data that APAP hepatotoxicity is a significant human health problem. 
 
Metabolism:  At therapeutic doses, the majority of APAP is metabolized in the liver by 
glucuronidation and sulfation to APAP-GLU and APAP-SUL conjugates, respectively (Heard, 
2008).  Only a small portion of APAP, approximately 5%, is metabolized in the liver by cytochrome 
P450 enzymes, Cyp1a2, Cyp3a11, and Cyp2e1, to a toxic reactive metabolite N-acetyl-p-
benzoquinone imine (NAPQI) (Dahlin, 1984) which is efficiently inactivated by hepatic GSH pools 
(Chen, 2003).  At toxic doses, however, the glucuronidation and sulfation pathways become 
saturated and an excess amount of NAPQI is formed leading to a rapid depletion of hepatic GSH.  
NAPQI, in turn, covalently binds to cellular macromolecules resulting in the production of reactive 
oxygen species and leading to oxidative stress and hepatocellular damage (Jaeschke, 2006). 
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Nrf2 and APAP Hepatotoxicity:  APAP leads to the nuclear accumulation of Nrf2 in mouse liver 
(Goldring, 2004).  Various studies have shown increased expression of downstream Nrf2 target 
genes in mouse liver following APAP administration including Nqo1, Ho-1, and Gclc (Goldring, 
2004, Aleksunes, 2006b).  Similar observations have also been observed for Nqo1 in human liver 
tissue samples obtained during transplantation following APAP overdose (Aleksunes, 2006a). 
 Nrf2-null mice exhibit enhanced hepatocellular injury compared to their wild-type 
counterparts following APAP administration (Chan, 2001, Enomoto, 2001).  Reduced APAP-GLU 
conjugate formation was hypothesized to contribute to this increased susceptibility of Nrf2-null 
mice to APAP-induced hepatotoxicity.  This was supported by enhanced immunohistochemical 
staining of APAP-adducted proteins in Nrf2-null mouse liver sections as well as lower mRNA 
expression and activity of Ugt1a6, an enzyme involved in the glucuronidation and detoxification of 
APAP (Enomoto, 2001).  Nrf2-null mice also exhibit lower basal expression of downstream Nrf2 
target genes including Nqo1 and Gclc (Aleksunes, 2008).  Furthermore, hepatic mRNA expression of 
these genes is significantly induced at 24 hours following APAP administration in wild-type mice, 
with a significant induction in protein seen at 48 hours, but no induction in mRNA or protein is 
observed in Nrf2-null mice (Aleksunes, 2008).  Nrf2 not only regulates the expression of genes 
involved in the metabolism of APAP, but additionally influences the expression of cytoprotective 
genes associated with alleviating APAP hepatotoxicity. 
 
Differential Susceptibility of Males and Females to APAP Hepatotoxicity 
 Sex is known to play an important role in drug absorption, metabolism, distribution, and 
excretion (Morris, 2003, Tanaka, 1999).  Previous work has shown sex differences in susceptibility to 
APAP hepatotoxicity in mice, however, the mechanism(s) underlying these sex differences remains 
unknown.  Interestingly, in CD-1 mice, one study reported no sex differences with respect to 
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APAP-induced hepatotoxicity (Hoivik, 1995), however, a more recent study suggests that female 
CD-1 mice are more resistant to APAP-induced hepatotoxicity than their male counterparts 
(Masubuchi, 2011).  This latter study observed elevated alanine aminotransferase (ALT) activity in 
male CD-1 mice but not in female CD-1 mice following APAP administration.  Furthermore, 
histological examination of liver tissue sections at 24 hours following APAP administration revealed 
hemorrhage and centrilobular necrosis only in the male CD-1 mice.  The factors responsible for the 
variations in the results of these studies is unknown but may be a result of differing dosing regimens.  
Recent studies have also shown that male C57BL/6 mice are more susceptible to APAP 
hepatotoxicity than their female counterparts (Dai, 2006, McConnachie, 2007).  For these reasons, 
male mouse models are more often employed in APAP-induced hepatotoxicity studies than female 
mouse models.  This subsequently results in only a small amount of literature exploring the 
differential susceptibility of male and female mice to APAP-induced hepatotoxicity. 
 A recent study has also suggested that acetaminophen metabolism does not contribute to sex 
differences in its hepatotoxic effect in mice (Dai, 2006).  It is known that APAP is metabolized by 
Cyp1a2, Cyp3a11, and Cyp2e1 to the toxic reactive metabolite NAPQI.  This 2006 study reported 
observing significantly lower basal level mRNA expression of Cyp1a2 in livers of female than male 
mice (Dai, 2006).  However, further analysis showed no significant sex differences in NAPQI 
covalent binding, suggesting that bioactivation of APAP is similar between sexes. 
 In humans, the differential susceptibility of males and females to APAP hepatotoxicity is less 
clear.  A higher female predominance of acetaminophen-related acute liver failure (ALF) cases has 
been observed both in the United States (Larson, 2005) and Sweden (Wei, 2007), suggesting that 
females with acute liver injury are either more predisposed to develop ALF or utilize prescription 
and/or over-the-counter medications containing acetaminophen more frequently than men.  
However, these data may be influenced by other factors as well including concomitant alcohol use, 
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concurrent medications, or nutritional status.  Additionally, recent studies show the prevalence, 
incidence, and morbidity risk of depressive disorders is higher among females than males (Piccinelli, 
2000, Pratt, 2008), and depressive disorders can often lead to self-medication, often times 
compounding the deleterious effects of the condition and leading to suicidal thoughts or actions 
(Zwolinski, 2010).  Furthermore, nearly half of all acetaminophen-related ALF cases are a result of 
an intentional overdose (Larson, 2005).  Although not every acetaminophen-related ALF case 
resulting from an intentional overdose may be attributed to a concomitant depressive disorder, 
acetaminophen is also not likely the sole factor resulting in a greater predominance of ALF cases in 
female than male humans.  On the other hand, mouse models of APAP-induced hepatotoxicity are 
bred and maintained in a tightly controlled environmental setting, without the confounding 
influence of these added factors or conditions. 
 
Sex Differences of Nrf2-Responsive Genes 
NAD(P)H Quinone Oxidoreductase 1:  While there are no reports of sex differences of Nqo1 
expression in mice, one recent study has reported sex differences in the rat.  This study observed 
significantly higher basal mRNA, protein, and enzymatic activity levels of Nqo1 in Sprague Dawley 
female than male rats, and these differences remained significant following APAP administration 
(Augustine, 2008).  However, differences in the mRNA, protein, and enzymatic activity of Nqo1 
were not observed in August Copenhagen x Irish (ACI) rat strains.  While both rat strains are 
commonly employed in drug-induced enzyme induction and toxicity studies, sex differences in 
Nqo1 mRNA and protein expression and enzymatic activity levels are strain-dependent.  This 
finding can, therefore, serve as an important tool when using rat models for toxicity studies. 
 
 11 
 
Multidrug Resistance-Associated Protein Transporters:  It is known that Nrf2 plays a predominant role in 
the hepatic induction of the Mrp family of proteins (Maher, 2005).  Furthermore, one study has 
shown that Mrp4 mRNA expression levels are more pronounced in female than male CD-1 mice at 
a low dose of APAP (Masubuchi, 2011).  The absence of a significant Mrp4 mRNA response at a 
higher dose may be due to impaired gene regulation resulting from pronounced hepatocellular 
necrosis. 
 
Glutamate Cysteine Ligase:  A greater number of studies suggest sex differences in glutamate cysteine 
ligase.  One study observed greater mRNA induction of Gclc in female than male CD-1 mice 
following APAP administration at 300 mg/kg (Masubuchi, 2011).  An earlier study also reported 
greater APAP-induced hepatotoxicity in male than female Gclm wild-type C57BL/6 mice 
(McConnachie, 2007).  Finally, a more recent study reported that pretreatment of mice with 
buthionine sulfoximine (BSO), an inhibitor of glutamate cysteine ligase, potentiates APAP 
hepatotoxicity in female mice.  These findings suggest a role for glutamate cysteine ligase in the 
differential susceptibility of male and female mice to APAP-induced hepatotoxicity.  However, 
glutamate cysteine ligase is involved in the formation of glutathione (GSH) which plays an important 
role in the detoxification of NAPQI, the toxic reactive metabolite formed as a result of APAP 
metabolism, and it remains unclear whether there is a differential expression of GSH between males 
and females.  One study shows no basal differences in hepatic GSH levels in overnight-fasted CD-1 
male and female mice (Masubuchi, 2011).  However, another study reports significantly lower basal 
GSH levels in male than female mouse livers (Sheng, 2013).  These variations in the literature may 
be due to differences across strains and/or differences across experimental methodologies (e.g. time 
points of analysis, overnight-fasting versus continued feeding). 
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While there is a small amount of literature already available that explores the differential 
susceptibility of males and females to APAP-induced hepatotoxicity, many questions still remain 
unanswered about the mechanism(s) involved in this differential susceptibility.  Because many of the 
cytoprotective genes associated with APAP hepatotoxicity are regulated by the nuclear transcription 
factor Nrf2, it is important to understand the potential influence Nrf2 has on the differential 
susceptibility of males and females to APAP-induced hepatotoxicity. 
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Chapter Two 
 
Let’s Talk Sex: Is Nrf2 Responsible for Sex Differences in Susceptibility to  
Acetaminophen-Induced Hepatotoxicity in Mice? 
 
ABSTRACT 
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively 
regulates the expression and activity of cytoprotective genes during periods of oxidative stress.  It 
has previously been shown that some of these cytoprotective genes are more highly expressed in 
livers of female than male mice.  This could explain previously reported sex-related differences in 
susceptibility to acetaminophen (APAP) hepatotoxicity in mice, where females show greater 
resistance to APAP hepatotoxicity.  Here, we examined differences in basal mRNA and protein 
expression for Nrf2 and Nrf2-dependent genes and measured glutathione (GSH) levels in naïve fed 
wild-type (WT) male and female mice and overnight-fasted WT and Nrf2-null male and female mice 
following either vehicle or APAP administration.  Alanine aminotransferase (ALT) activity was also 
measured as an indicator of hepatotoxicity.  Hepatic mRNA and protein levels were measured by 
quantitative PCR and western blotting, respectively.  Basal Nrf2 mRNA expression was significantly 
lower in livers of naïve female than male mice.  In agreement with mRNA expression, basal Nrf2 
protein expression was lower in livers of both naïve and overnight-fasted WT female than male 
mice, with significance observed in livers of naïve mice.  Basal mRNA expression of the Nrf2-
regulated gene NAD(P)H quinone oxidoreductase 1 (Nqo1) was significantly greater in livers of 
overnight-fasted WT female than male mice, however, no significant differences between sexes for 
the remaining Nrf2-regulated genes were observed.  Interestingly, basal Nqo1 protein expression 
was significantly higher in livers of naïve and overnight-fasted WT and Nrf2-null female than male 
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mice.  Furthermore, a significantly greater induction of Nqo1 and multidrug resistance-associated 
protein 4 (Mrp4) mRNA expression was observed in both naïve and overnight-fasted WT and Nrf2-
null female than male livers following APAP administration, resulting in significantly greater mRNA 
expression of these genes in female than male livers.  ALT activity was also significantly elevated in 
both overnight-fasted WT and Nrf2-null male mice following APAP administration, but no 
increases in ALT were observed in either genotype of female mice.  These results indicate that other 
factors, rather than Nrf2, are responsible for the lower susceptibility of female mice to APAP 
hepatotoxicity. 
 
INTRODUCTION 
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively 
regulates the expression and activity of cytoprotective genes during periods of oxidative stress. In its 
inactive state, Nrf2 is bound to Kelch-like ECH-associated protein 1 (Keap1) in the cytoplasm of 
the cell (Itoh, 1999, Kang, 2004).  However, in the presence of oxidative stress, Nrf2 dissociates 
from Keap1 and translocates into the nucleus of the cell leading to the activation of antioxidant 
response element (ARE)-mediated gene transcription.  ARE-containing genes identified as targets of 
Nrf2 are involved in a variety of cellular functions including drug metabolism, reactive oxygen 
species scavenging, GSH homeostatsis, and efflux transport pathways (Nguyen, 2003).  These genes 
include, among others, NAD(P)H quinone oxidoreductase 1 (Nqo1), heme oxygenase 1 (Ho-1), 
multidrug resistance-associated protein transporters (Mrp1-4), glutamate cysteine ligase catalytic 
subunit (Gclc), and glutamate cysteine ligase modifier subunit (Gclm) (Aleksunes, 2007).  An impaired 
expression of these genes can increase the sensitivity of cells to oxidative damage.  Previously, it has 
also been shown that many of these genes are more highly expressed in the livers of female than 
male mice (Masubuchi, 2011, Dai, 2006). 
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Acetaminophen (APAP) is a commonly used analgesic and antipyretic.  APAP is also one of 
the leading causes of acute liver failure in the United States (Reuben, 2010).  Since the early 2000’s, 
APAP has been attributed to approximately 50% of all acute liver failure cases across the United 
States (Reuben, 2010).  At therapeutic doses, the majority of APAP is metabolized in the liver by 
glucuronidation and sulfation to APAP-GLU and APAP-SUL conjugates, respectively (Heard, 
2008).  Only a small portion of APAP, approximately 5%, is metabolized in the liver by cytochrome 
P450 enzymes, Cyp1a2, Cyp3a11 (Cyp3a4 in humans), and Cyp2e1, to a toxic reactive metabolite N-
acetyl-p-benzoquinone imine (NAPQI) (Dahlin, 1984) which is efficiently inactivated by hepatic 
glutathione (GSH) pools (Chen, 2003).  At toxic doses, however, the glucuronidation and sulfation 
pathways become saturated and an excess amount of NAPQI is formed leading to a rapid depletion 
of hepatic GSH.  NAPQI, in turn, covalently binds to cellular macromolecules resulting in the 
production of reactive oxygen species and leading to oxidative stress and hepatocellular damage 
(Jaeschke, 2006).  Currently, N-Acetyl cysteine (NAC), a precursor to GSH, is the only standard 
therapy used to prevent and decrease APAP-induced hepatotoxicity.  However, this treatment is 
administered only in a hospital setting and must be administered within 8 hrs following overdose to 
be most effective (Algren, 2008).  In the case of accidental overdose, however, ALF may not be 
evident within 8 hrs, at which point administration of NAC is no longer beneficial (Larson, 2005). 
APAP has been shown to lead to the nuclear accumulation of Nrf2 in mouse liver 
(Goldring, 2004).  Various studies have also shown increased expression of downstream Nrf2 target 
genes in mouse liver following APAP administration including Nqo1, Ho-1, and Gclc (Goldring, 2004, 
Aleksunes, 2006b).  Furthermore, Nrf2-null mice exhibit enhanced hepatocellular injury compared 
to their wild-type counterparts following APAP administration (Chan, 2001, Enomoto, 2001), 
suggesting a pivotal hepatoprotective role for Nrf2 in APAP-induced hepatotoxicity. 
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Sex is known to play an important role in drug absorption, metabolism, distribution, and 
excretion (Morris, 2003, Tanaka, 1999).  Previous work has shown sex differences in susceptibility to 
APAP hepatotoxicity in mice, however, the mechanism(s) underlying these sex differences remains 
unknown.  Recent studies have shown that male C57BL/6 mice are more susceptible to APAP-
induced hepatotoxicity than their female counterparts (Dai, 2006, McConnachie, 2007).  However, 
in CD-1 mice, one study reported no sex differences with respect to APAP-induced hepatotoxicity 
(Hoivik, 1995), while a more recent study suggests that female CD-1 mice are more resistant to 
APAP-induced hepatotoxicity than their male counterparts (Masubuchi, 2011).  The latter study 
observed elevated alanine aminotransferase (ALT) activity in male CD-1 mice but not in female CD-
1 mice following APAP administration, and histological examination of liver tissue sections at 24 hrs 
following APAP administration revealed hemorrhage and centrilobular necrosis only in the male 
mice.  For these reasons, male mouse models are more often employed in APAP-induced 
hepatotoxicity studies than female mouse models.  This subsequently results in only a small amount 
of literature exploring the differential susceptibility of male and female mice to APAP-induced 
hepatotoxicity.  Interestingly, in humans, a higher female predominance of acetaminophen-related 
acute liver failure (ALF) cases has been observed both in the United States (Larson, 2005) and 
Sweden (Wei, 2007).  These data, however, may be influenced by concomitant alcohol use, 
concurrent medications, or nutritional status, for example. 
The present study aims to explore sex differences in the expression of various cytoprotective 
genes involved in APAP-induced hepatotoxicity in C57BL/6J mice.  Here, we hypothesized that 
resistance to APAP-induced hepatotoxicity by female mice is due to higher basal and inducible 
expression of Nrf2 and Nrf2-dependent genes.  We examined alanine aminotransferase (ALT) levels 
in male and female mice, measured mRNA and protein expression for Nrf2 and Nrf2-dependent 
genes, and measured hepatic GSH levels in male and female mice.  This study will aid in the 
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identification of potential new therapeutic gene targets for the treatment and prevention of drug-
induced liver injury. 
 
MATERIALS AND METHODS 
Reagents.  APAP was purchased from Sigma-Aldrich (St. Louis, MO). 
 
Animals and Treatment.  Male and female WT C57BL/6J mice were purchased from the Jackson 
Laboratory (Bar Harbor, ME).  Nrf2-/- (Nrf2-null) mice with a C57BL/6J background were kindly 
provided by Dr. Angela Slitt from the University of Rhode Island.  The mice utilized were age 
matched from 8.5 to 10.5 weeks of age.  All mice were housed and bred at the University of 
Connecticut in a temperature-, light-, and humidity-controlled environment that is accredited by the 
Association for Assessment and Accreditation of Laboratory Animal Care.  Mice were maintained 
on standard laboratory chow and had free access to water.  Male and female WT mice were either 
fasted overnight or maintained on the laboratory chow.  Male and female Nrf2-null mice were fasted 
overnight.  APAP was dissolved in saline (pH 8.0).  Mice received either no treatment or were 
administered APAP (200 mg/kg, 400 mg/kg or 600 mg/kg, i.p.) or saline as a vehicle treatment.  
Plasma and liver were collected at various time points.  A portion of the liver was fixed in 10% zinc 
formalin and the remaining liver tissue was snap frozen in liquid nitrogen.  Frozen tissues were 
stored at −80°C until assayed. All animal studies were conducted in accordance with National 
Institutes of Health standards and the Guide for the Care and Use of Laboratory Animals. Studies were 
approved by the University of Connecticut Institutional Animal Care and Use Committee (IACUC 
Protocol no. A12-050). 
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Assessment of Hepatotoxicity.  Plasma ALT activity was determined as a biochemical indicator of 
hepatocellular necrosis.  Infinity ALT Liquid Stable Reagent (Thermotrace, Melbourne, Australia) 
was used according to the manufacturer’s protocol.  Hepatotoxicity was confirmed by histological 
examination of liver tissue sections.  Formalin-fixed tissue sections were embedded in paraffin, 
mounted onto glass slides, stained with hematoxylin-eosin, and examined for histopathological 
changes by a board-certified veterinary pathologist. 
 
Preparation of Crude Membrane, Microsomal, Cytosolic, and Nuclear Fractions. Livers were homogenized in 
sucrose-Tris (ST) buffer (0.25 M sucrose, 10 mM Tris–HCl, pH 7.4) containing 50 μg/ml aprotonin 
and centrifuged at 100,000 × g for 60 min at 4°C. The resulting pellet constituted the crude 
membrane fraction and was resuspended in ST buffer. For isolation of microsomes, homogenates 
were first centrifuged at 10,000 × g for 20 min at 4°C. The supernatant was then centrifuged at 
100,000 × g for 60 min. ST buffer was used to resuspend the microsomal pellet. Liver cytosolic and 
nuclear extracts were prepared using the NE-PER Nuclear Extraction Kit according to the 
manufacturer’s directions (Pierce Biotechnology, Rockford, IL). Protein concentrations were 
determined using Bio-Rad protein assay reagents (Bio-Rad Laboratories, Hercules, CA).  Bovine 
serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO) was used as a standard. 
 
Western Blot Analysis. Cytosolic and nuclear proteins were boiled for 10 minutes. Proteins were 
electrophoretically resolved using polyacrylamide gels (8-12% resolving, 5% stacking) and 
transblotted onto PVDF-Plus membrane (Micron Separations, Westboro, MA). Immunochemical 
detection of Nrf2, Nqo1, Ho-1, Gclc, Gclm, Mrp3, and Mrp4 proteins are described in Table 2.  
Briefly, membranes were blocked with 5% non-fat dry milk (NFDM) in Tris-buffered saline-
0.1%Tween-20 (pH 7.4) (TBS-Tw) for 1 h and incubated overnight with the primary antibody 
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diluted in blocking buffer. A species-appropriate peroxidase-labeled secondary antibody (Sigma, St. 
Louis, MO) was diluted in blocking buffer and incubated with blots for 1 h.  Protein-antibody 
complexes were detected using a chemiluminescent kit (Thermo Scientific, IL) followed by exposure 
to X-ray film. Intensity values were normalized to TBP for Nrf2 and β-actin for remaining proteins. 
 
Quantitative RT-PCR. Real time PCR (qRT-PCR) was carried out using an Applied Biosystems 7500 
Fast qRT-PCR Machine. Primers for Nrf2, Keap1, Nqo1, Ho-1, Gclc, Gclm, Mrp3, and Mrp4 were 
obtained from Integrated DNA Technologies and gene levels were normalized to β-Tubulin.  Primer 
sequences are shown in Table 3. 
 
Measurement of GSH Levels.  Total GSH was measured as previously described (Rahman, 2006).  
Briefly, livers were homogenized in 500 μl of buffer containing 0.2% Triton-X 100 and 0.6% 
sulfosalicyclic acid in 0.1 M potassium phosphate buffer with 5 mM EDTA disodium salt (KPE), 
pH 7.5.  20 μl of standards and samples were pipetted into a 96-well microtiter plate.  60 μl of β-
NADPH (Sigma, St. Louis, MO) was added followed by 120 μl of 1:1 3.33 U/ml glutathione 
reductase (Sigma, St. Louis, MO) with 0.67 mg/ml 5,5’-Dithiobis (2-nitrobenzoic acid, DTNB).  
Yellow 5-thio-2-nitrobenzoic acid (TNB) formation was monitored spectrophotometrically at 
412 nm.  The rate of formation of TNB is proportional to the concentration of GSH in the sample. 
 
Statistical Analysis.  Data were given as mean ± SD.  Data were analyzed using the Student t-test or 
one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test to determine 
significant differences between group means.  Significance was set at p < 0.05. 
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RESULTS 
Plasma ALT activity and histopathology in WT mice following APAP 
APAP-induced hepatocellular injury was assessed by plasma ALT levels and confirmed by 
histological examination of liver tissue sections.  At 400 mg APAP/kg, significant elevations in 
plasma ALT activity at 4 and 24 hrs were detected in male WT mice (Figure 1A).  However, ALT 
activity at 4 and 24 hrs after APAP did not increase in female WT mice.  Histological examination 
and grading of WT male and female liver tissue sections at 4 and 24 hrs after treatment with APAP 
was further indicative of hepatocellular damage in male but not female WT mice.  Centrilobular 
necrosis was observed in male livers at 4 hrs after treatment with APAP and this damage was even 
further pronounced at 24 hrs (Figure 1D-E).  No significant damage was observed in female livers at 
either time point (Figure 1B-C).  Histological grading further confirms these results (Table 1).  In 
Table 1, liver sections with grades higher than 2 are considered to have significant injury.  Treatment 
with 400 mg APAP/kg resulted in significant injury in 80% of male WT mice at 24 hrs following 
APAP treatment, however, no significant injury in female livers was observed. 
 
Hepatic mRNA expression of Nrf2 and Nrf2-dependent genes in naïve WT mouse livers 
Hepatic mRNA expression was measured for Nrf2, Keap1, and Nrf2-dependent genes Nqo1, 
Ho-1, Gclc, Gclm, Mrp3, and Mrp4 (Figure 2A-H).  Nrf2 hepatic mRNA levels in naïve WT females 
were significantly lower compared to male values (Figure 2A).  No significant differences in mRNA 
expression between female and male livers were observed for the remaining genes. These results are 
consistent with previous literature which shows similar basal mRNA levels of Gclc in male and 
female mouse livers (Masubuchi, 2011).  Masubuchi (2011) also showed significantly greater basal 
mRNA expression of Mrp4 in female mouse livers compared to male livers.  In the current study, 
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however, while greater basal mRNA expression of Mrp4 was observed in female livers compared to 
male livers, this difference was not significant. 
 
Hepatic mRNA expression of Nrf2 and Nrf2-dependent genes in overnight-fasted WT 
mouse livers following APAP 
Hepatic mRNA expression was measured for Nrf2, Keap1, and Nrf2-dependent genes Nqo1, 
Ho-1, Gclc, Gclm, Mrp3, and Mrp4 (Figure 3A-H).  Hepatic basal Nrf2 mRNA expression was slightly 
higher in females compared to males, although this difference was not significant.  Consistent with 
the naïve WT mouse data, no significant differences in basal mRNA expression in livers of 
overnight-fasted WT female and male mice were observed for the Nrf2-dependent genes examined, 
with the exception of Nqo1.  Hepatic basal mRNA expression of Nqo1 was significantly greater in 
female livers compared to male values at 4 hrs (Figure 3C).  In naïve WT female livers, basal mRNA 
expression of Nqo1 was greater than in naïve WT male livers, although this difference was not 
significant (Figure 2C).  The significant difference in hepatic basal mRNA expression of Nqo1 in the 
overnight-fasted WT mice may be a consequence of fasting-induced oxidative stress; however, 
previous literature shows no significant difference in basal mRNA expression of Nqo1 in liver 
between sexes for fed versus 24h-fasted mice (Zhang, 2013). 
A significant induction in Gclc mRNA levels was also observed in livers of overnight-fasted 
WT females at 4 hrs following APAP administration (Figure 3E).  This is consistent with previous 
work which shows elevated Gclc mRNA levels in livers of female mice following APAP 
administration (Masubuchi, 2011).  Mrp4 mRNA expression was also greatly elevated in livers of 
overnight-fasted WT females at 24 hrs following APAP administration.  Mrp1-4 are plasma 
membrane efflux transporter proteins that are believed to be involved in the antioxidant response 
through mediating the efflux of xenobiotics from the liver into the bile or blood (Klaassen, 2005).  
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Previous literature has shown Mrp4 to be a highly inducible antioxidant response protein in the liver 
of male and female mice following APAP administration (Aleksunes, 2008, Masubuchi, 2011). 
 
Hepatic protein expression of Nrf2 and Nrf2-dependent genes in naïve WT mouse livers 
Hepatic protein expression was measured for Nrf2 and Nrf2-dependent genes Nqo1, Gclc, 
Gclm, Mrp3, and Mrp4 (Figure 4A-F).  Similar to mRNA expression, Nrf2 protein expression was 
significantly lower in female livers compared to male livers (Figure 4A).  Hepatic protein expression 
for the remaining genes, except Gclc, followed a similar pattern with mRNA expression.  That is, if 
mRNA expression was lower in female livers than male livers, protein expression was also observed 
to be lower in female livers compared to male livers.  Significance in protein expression was 
observed for Nqo1, Gclc, Gclm, and Mrp3.  While female livers showed significantly greater Nqo1 
protein expression than male livers (Figure 4B), Gclm and Mrp3 protein expression was significantly 
lower in female than male livers (Figure 4D-E).  Gclc protein expression was significantly higher in 
female than male livers (Figure 4C), though Gclc mRNA expression, while not statistically significant, 
appeared lower in female livers compared to male livers (Figure 2E). 
 
Hepatic protein expression of Nrf2 and Nrf2-dependent genes in overnight-fasted WT 
mouse livers following APAP 
Hepatic protein expression was measured for Nrf2 and Nrf2-dependent genes Nqo1, Ho-1, 
Gclc, Gclm, Mrp3, and Mrp4 (Figure 5A-N).  Similar to protein expression in naïve WT mouse 
livers, Nrf2 protein expression was less pronounced in livers of overnight-fasted WT female than 
male mice following either vehicle or APAP administration.  Of the Nrf2-dependent genes 
examined, females did not exhibit a higher global expression of these genes.  Consistent with mRNA 
expression, basal protein expression of Nqo1 was significantly greater in female livers compared to 
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male livers at 4 hrs following vehicle treatment (Figure 5C).  Female livers also showed significantly 
greater Mrp4 basal protein expression than male livers at both 4 hrs and 24 hrs following vehicle 
treatment (Figure 5M-N).  No significant differences in basal protein expression between sexes were 
observed for the remaining genes.  A significant induction in Ho-1 protein expression was observed 
in both sexes at 24 hrs following APAP administration (Figure 5D).   This is consistent with 
previous work in our lab which shows Ho-1 is a highly inducible stress protein (Aleksunes, 2008). 
Consistent with protein expression in naïve WT livers, basal protein expression of Gclc was 
higher in livers of overnight-fasted WT females compared to males, although this difference was not 
significant.  Gclc protein expression was significantly decreased in female livers at 4 hrs following 
APAP administration (Figure 5G), but returned to basal levels at 24 hrs (Figure 5H).  No significant 
differences in Gclc protein expression in male livers were observed following APAP administration.  
These results are consistent with previous studies showing Gclc protein expression is significantly 
reduced in female mouse livers following APAP administration while no significant differences in 
male livers were observed (Sheng, 2013).  Furthermore, although not significant, Gclm protein 
expression was higher in female livers compared to male livers at 4 hrs and 24 hrs following either 
vehicle or APAP administration (Figure 5I-J).  Gclc and Gclm are enzymes involved in the 
production of GSH, an important detoxification pathway in APAP hepatotoxicity.  These data 
suggest a greater propensity for females to produce more GSH than males following APAP 
treatment. 
 
Hepatic glutathione measurement in WT mice following APAP 
To investigate potential sex differences in hepatic GSH levels, total GSH was measured, as 
described in the materials and methods, in livers of naïve WT male and female mice as well as 
overnight-fasted WT male and female mice following either vehicle or APAP administration.  No 
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significant differences in basal GSH levels were observed between livers of naïve or overnight-fasted 
WT male and female mice (Figures 6-7).  However, a significantly greater reduction in GSH at 4 hrs 
following APAP administration was observed in overnight-fasted WT male livers compared to 
female livers (Figure 7).  This is consistent with observations of lower toxicity and liver damage in 
female livers compared to male livers.  Glutathione levels rebound in both sexes at 24 hrs following 
APAP administration (Figure 7), consistent with an increase in Gclc mRNA expression in both sexes 
at 4 hrs following APAP administration (Figure 3E). 
 
Plasma ALT activity and histopathology in Nrf2-null mice following APAP 
To better understand whether Nrf2 is responsible for the sex differences in susceptibility of 
male and female mice to APAP-induced hepatotoxicity, ALT activity was measured in Nrf2-null 
male and female mice following APAP treatment.  At 200 mg APAP/kg, significant elevation in 
plasma ALT activity at 24 hrs was detected in male Nrf2-null mice (Figure 8A).  However, no 
significant change in ALT activity was observed in females of the same genotype (Figure 6A).  
Histological examination and grading of liver tissue sections from male and female Nrf2-null mice at 
24 hrs following APAP administration further confirms these results (Figures 8C-D, Table 1).  
Treatment with 200 mg APAP/kg resulted in significant injury in 60% of male Nrf2-null mice 
compared to 0% of female Nrf2-null mice (Table 1).  Furthermore, at 400 mg APAP/kg, 
significantly elevated ALT activity was still not observed in female Nrf2-null mice (Figure 8B) and 
histological grading did not detect significant injury in female Nrf2-null mice following APAP 
treatment at 400 mg/kg (Table 1).  However, at 600 mg APAP/kg, significantly elevated ALT 
activity was observed in female Nrf2-null mice (Figure 8B).  Histological examination and grading 
further confirmed the presence of hepatocellular damage in liver tissue sections of female Nrf2-null 
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mice following APAP treatment at 600 mg APAP/kg (Figure 8F, Table 1).  Significant injury in 75% 
of female Nrf2-null mice resulted following treatment with 600 mg APAP/kg (Table 1). 
 
Hepatic mRNA expression of Nrf2-dependent genes in Nrf2-null mouse livers following 
APAP 
Hepatic mRNA expression was measured for Keap1 and Nrf2-dependent genes Nqo1, Ho-1, 
Gclc, Gclm, Mrp3, and Mrp4 (Figure 9A-G).  Significant induction of Ho-1 was observed in male livers 
at 24 hrs following APAP treatment (Figure 9B).  Ho-1 catabolizes prooxidant heme to carbon 
monoxide, biliverdin, and free iron, thereby preventing free heme from facilitating the formation of 
reactive oxygen species (Aleksunes, 2007).  These results are consistent with previous literature that 
show Ho-1 is upregulated following oxidative stress and cellular injury (Guo, 2001, Aleksunes, 2008). 
Similar to the overnight-fasted WT mouse livers, Nrf2-null female mouse livers showed 
significant induction of Nqo1 and Mrp4 mRNA expression at 24 hrs following APAP treatment 
(Figure 9C & G).  Furthermore, at 24 hrs following APAP treatment, female livers showed 
significantly greater mRNA expression of Nqo1, Mrp3, and Mrp4 than male livers (Figure 9C, F & 
G).  These data suggest that other mechanisms in addition to Nrf2 or in compensation for the 
absence of Nrf2 may regulate the transcription of Nqo1 and Mrp4 in females. 
 
Hepatic protein expression of Nrf2-dependent genes in Nrf2-null mouse livers following 
APAP 
Hepatic protein expression was measured for Nrf2-dependent genes Nqo1, Ho-1, Gclc, 
Gclm, Mrp3, and Mrp4 (Figure 10A-F).  Nrf2-null female livers showed significantly greater Nqo1 
basal protein expression than their male counterparts at 24 hrs following vehicle treatment (Figure 
10B).  No significant differences between sexes were observed for the remaining genes.  A 
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significant reduction in Gclc protein expression was observed in female livers at 24 hrs following 
APAP treatment (Figure 10C).  A similar reduction was observed at 4 hrs following APAP treatment 
in female overnight-fasted WT mouse livers (Figure 5G). 
 
Hepatic glutathione measurement in Nrf2-null mice following APAP 
Total GSH was measured in livers of Nrf2-null male and female mice following either 
vehicle or APAP administration.  A significantly greater reduction in GSH was observed in male 
than female livers at 24 hrs following APAP treatment (Figure 11).  This is consistent with 
observations in livers of overnight-fasted WT male and female mice (Figure 7) and observations of 
lower toxicity and liver damage in Nrf2-null female than male livers. 
  
 27 
 
 
 
 
 
 
 
 
 
Figure 1.  Sex differences in APAP hepatotoxicity in mice.  Male and female mice were sacrificed at 
4 and 24 hrs following APAP administration.  (A) Serum ALT activity in overnight-fasted WT mice 
following APAP administration (400mg/kg, i.p.).  Data are presented as mean ± SD (n = 6 animals).  
Data were analyzed using ANOVA followed by Tukey’s multiple comparison test.  Asterisks (*) 
represent statistical differences (p<0.05) between groups. (B-E) Histopathology of liver sections.  
Liver sections from male and female overnight-fasted WT mice at 4 and 24 hrs following vehicle or 
APAP treatment were subjected to hematoxylin-eosin staining (10x final magnification).  Samples 
are as follows: B, female/WT/400mg/kg APAP/4h; C, female/WT/400mg/kg APAP/24h; D, 
male/WT/400mg/kg APAP/4h; E, male/WT/400mg/kg APAP/24h.  Vehicle not shown. 
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Table 1. Histopathological analysis of livers from APAP-treated WT and Nrf2-null mice.  Livers 
were removed from WT and Nrf2-null mice 4 and 24 hrs following vehicle or APAP (200 mg/kg, 
400 mg/kg, or 600 mg/kg) administration and fixed in 10% formalin prior to paraffin embedding 
and staining with hematoxylin and eosin. Liver sections were evaluated for the severity of 
degenerative and necrotic changes in the centrilobular regions as previously described (Manautou et 
al., 1994, Aleksunes et al., 2005). Liver samples with grades greater than 2 are considered to have 
significant injury. Data were rank ordered prior to statistical analysis. Asterisks (*) represent a 
statistical difference (p < 0.05) from control mice of the same genotype and sex. Daggers (†) 
represent a statistical difference (p < 0.05) from WT mice of the same treatment and sex. 
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WT 0 1 2 3 4 5 % > 2 Total
4 hrs
Male
Vehicle 3 0 3
400 mg APAP/kg 5 0* 5
Female
Vehicle 3 0 3
400 mg APAP/kg 4 0 4
24 hrs
Male
Vehicle 3 0 3
400 mg APAP/kg 1 4 80* 5
Female
Vehicle 3 0 3
400 mg APAP/kg 5 0 5
Nrf2-null
24 hrs
Male
Vehicle 4 0 4
200 mg APAP/kg 1 1 1 2 60
*
5
Female
Vehicle 6 0 6
200 mg APAP/kg 3 1 0 4
400 mg APAP/kg 1 2 1 1 20 5
600 mg APAP/kg 1 2 1 75* 4
Histological Grade
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Figure 2.  Messenger RNA expression of Nrf2, Keap1, and Nrf2-regulated genes in male and female 
naïve WT mouse livers.  Data are presented as mean ± SD.  Data were analyzed using the Student t-
test.  Asterisks (*) represent statistical differences (p<0.05) between sexes. 
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Figure 3.  Hepatic messenger RNA expression of Nrf2, Keap1, and Nrf2-regulated genes in vehicle- 
and APAP-treated (400 mg/kg, i.p.) overnight-fasted WT male and female mice.  Data are presented 
as mean ± SD (n = 6 animals).  Data were analyzed using ANOVA followed by Tukey’s multiple 
comparison test.  Asterisks (*) represent statistical differences (p<0.05) between groups. 
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Figure 4.  Western blots for Nrf2 and Nrf2-regulated genes were performed using liver membrane 
(Mrp3 and Mrp4), cytosolic (Nqo1, Gclc, and Gclm), and nuclear (Nrf2) preparations from naïve 
WT male and female mice.  Human hepatocyte-derived HCO4 cells treated with 100μM tBHP for 2 
hrs were used as a positive control for Nrf2 detection.  Nrf2-null mouse liver tissue was used as a 
negative control for Nrf2 detection.  Equal protein loading was confirmed by detection of TBP for 
Nrf2 and β-actin.  Data are presented as blots (upper panel) and as mean ± SD (n = 6 animals) 
(lower panel).  Data were analyzed using the Student t-test.  Asterisks (*) represent statistical 
differences (p<0.05) between sexes. 
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Figure 5.  Western blots for Nrf2 and Nrf2-regulated genes were performed using liver membrane 
(Mrp3 and Mrp4), cystolic (Nqo1, Ho-1, Gclc, and Gclm), and nuclear (Nrf2) preparations from 
vehicle- and APAP-treated (400 mg/kg, i.p.) overnight-fasted WT male and female mice.  Human 
hepatocyte-derived HCO4 cells treated with 100μM tBHP for 2 hrs were used as a positive control 
for Nrf2 detection.  Equal protein loading was confirmed by detection of TBP for Nrf2 and β-actin.  
Data are presented as blots (upper panel) and as mean ± SD (n = 3 animals) (lower panel).  Data 
were analyzed using ANOVA followed by Tukey’s multiple comparison test.  Asterisks (*) represent 
statistical differences (p<0.05) between groups. 
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Figure 6. GSH content in naïve wild-type mouse livers.  Hepatic GSH levels were measured in male 
and female naïve WT mice.  Data were analyzed using the Student t-test.  Data are presented as 
mean ± SD (n=6 animals).  Data were analyzed using the Student t-test.  Asterisks (*) represent a 
statistical difference (p<0.05) between sexes. 
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Figure 7.  Hepatic GSH levels were measured in vehicle- and APAP-treated (400 mg/kg, i.p.) 
overnight-fasted WT male and female mice.  Data are presented as mean ± SD (n=6 animals).  Data 
were analyzed using ANOVA followed by Tukey’s multiple comparison test.  Asterisks (*) represent 
statistical differences (p<0.05) between groups. 
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Figure 8.  Sex differences in APAP hepatotoxicity in mice.  Male and female mice were sacrificed at 
24 hrs following APAP administration.  (A) Serum ALT activity in Nrf2-null mice at 24 hrs 
following APAP administration (200mg/kg, i.p., n = 4 to 5 animals).  (B) Serum ALT activity in 
Nrf2-null female mice at 24 hrs following APAP administration (400mg/kg and 600mg/kg, i.p., n = 
4 to 5 animals).  Data are presented as mean ± SD.  Data were analyzed using ANOVA followed by 
Tukey’s multiple comparison test.  Asterisks (*) represent statistical differences (p<0.05) between 
groups.  (C-F) Histopathology of liver sections.  Liver sections from male and female Nrf2-null mice 
at 24 hrs following vehicle or APAP administration were subjected to hematoxylin-eosin staining 
(10x final magnification).  Samples are as follows: C, female/Nrf2-null/200mg/kg APAP/24h; D, 
male/Nrf2-null/200mg/kg APAP/24h; E, female/Nrf2-null/400mg/kg APAP/24h; F, 
female/Nrf2-null/600mg/kg APAP/24h.  Vehicle not shown. 
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Figure 9.  Hepatic messenger RNA expression of Keap1, and Nrf2-regulated genes in vehicle- and 
APAP-treated (200 mg/kg, i.p.) male and female Nrf2-null mice.  Data are presented as mean ± SD 
(n = 4 to 5 animals).  Data were analyzed using ANOVA followed by Tukey’s multiple comparison 
test.  Asterisks (*) represent statistical differences (p<0.05) between groups. 
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Figure 10.  Western blots for Nrf2-regulated genes were performed using liver membrane (Mrp3 
and Mrp4) and cytosolic (Nqo1, Gclc, and Gclm) preparations from Nrf2-null male and female 
mice.  Equal protein loading was confirmed by detection of β-actin.  Data are presented as blots 
(upper panel) and as mean ± SD (n = 3 animals) (lower panel).  Data were analyzed using ANOVA 
followed by Tukey’s multiple comparison test.  Asterisks (*) represent statistical differences (p<0.05) 
between groups. 
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Figure 11.  Hepatic GSH levels were measured in vehicle- and APAP-treated (200 mg/kg, i.p.) male 
and female Nrf2-null mice at 24h.  Data are presented as mean ± SD (n=4 to 5 animals).  Data were 
analyzed using ANOVA followed by Tukey’s multiple comparison test.  Asterisks (*) represent 
statistical differences (p<0.05) between groups. 
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Table 3 - Primer Sequences for Quantitative RT-PCR
Gene Primer Sequences
Nrf2 Forward:  5’ – TCTATGTCTTGCCTCCAAAGG – 3’
Reverse:  5’ – CTCAGCATGATGGACTTGGA – 3’
Keap1 Forward:  5’ – GGCAGTGTGACAGGTTGAAG – 3’
Reverse:  5’ – GATCGGCTGCACTGAACTG – 3’
Nqo1 Forward:  5’ – TTTAGGGTCGTCTTGGCAAC – 3’
Reverse:  5’ – GTCTTCTCTGAATGGGCCAG – 3’
Ho-1 Forward:  5’ – GAGCCTGAATCGAGCAGAAC – 3’
Reverse:  5’ – CCTTCAAGGCCTCAGACAAA – 3’
Gclc Forward:  5’ – CTGCACATCTACCACGCAGT – 3’
Reverse:  5’ – TTCATGATCGAAGGACACCA – 3’
Gclm Forward:  5’ – CGGGAACCTGCTCAACTG – 3’
Reverse:  5’ – TTGGGAACTCCATTCATTCA – 3’
Mrp3 Forward:  5’ – AGTGGCTGTGATAGTCTTGCTGATA – 3’
Reverse:  5’ – CCGTTCAGGATCTCGCTCAT – 3’
Mrp4 Forward:  5’ – ACCTCTGCTCGCGCGTGTTCT – 3’
Reverse:  5’ – CCAGTACCGTTGAAGCTCCTCTCC – 3’   
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DISCUSSION 
Nrf2 regulates a plethora of genes shown to protect against drug-induced liver toxicity 
following toxic doses of APAP (Aleksunes, 2007).  Furthermore, sex differences in susceptibility to 
APAP-induced hepatotoxicity have also been reported, where female mice show greater resistance 
to APAP-induced hepatotoxicity than their male counterparts.  In the present study, we have 
demonstrated that Nrf2 is not responsible for this sex difference.  Lower Nrf2 mRNA and protein 
expression was observed in livers of naïve WT female mice as well as overnight-fasted WT female 
mice following vehicle- or APAP-treatment than in livers of male mice.  Most notably, while ALT 
activity was significantly elevated in both WT and Nrf2-null male mice following APAP 
administration, no increases in ALT were observed in either genotype of female mice. 
Interestingly, hepatic basal and APAP-inducible mRNA levels of Nqo1 and Mrp4 were 
consistently higher in naïve and overnight-fasted WT and Nrf2-null females than males.  This 
finding suggests that other factors differentially expressed in male and female mice, with greater 
expression in females than males, may regulate the transcription of these two genes, thereby 
resulting in greater resistance of female than male mice to APAP-induced hepatotoxicity.  Future 
studies are needed to better understand the sex-dependent susceptibility of mice to APAP 
hepatotoxicity. 
In addition to Nrf2, other nuclear transcription factors including peroxisome proliferator-
activated receptor alpha (PPARα), aryl hydrocarbon receptor (AhR), and c-Jun N-terminal kinase 
(JNK) also regulate the expression and activity of many cytoprotective genes associated with APAP 
hepatotoxicity.  For example, JNK facilitates the transcription of genes involved in cytoprotection 
containing activator protein-1 (AP-1) binding sites within their promoter regions including 
Glutathione S-Transferases (Gsts) (Elsby, 2003).  APAP is known to induce AP-1 binding activity, 
suggesting that JNK may play a protective role against APAP-induced hepatotoxicity.  Interestingly, 
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recent literature has shown 10-fold greater basal expression of mRNA for the Gst isoform Gstπ in 
livers of male mice compared to females (Dai, 2006) and there is evidence that Gstπ may be a direct 
inhibitor of JNK (Elsby, 2003).  Recent studies have also shown that Gstπ-null mice show increased 
resistance to APAP-induced hepatotoxicity (Henderson, 2000) and the absence of Gstπ elevates the 
expression of Ho-1 in liver (Elsby, 2003).  Gstπ is the most abundant Gst isoform in mouse liver 
(Kitteringham, 2003).  Further research is necessary to understand whether sex differences in Gstπ 
expression may influence JNK expression and sex-dependent susceptibility to APAP hepatotoxicity. 
Recent literature has also demonstrated the protective effect of 17β-Estradiol against APAP-
induced hepatotoxicity (Chandrasekaran, 2011).  Estrogens are known to elicit antioxidant effects, 
protecting numerous tissues including the liver (Huh, 1994) from oxidative stress-induced damage.  
Estradiol has been shown to significantly reduce malondialdehyde (MDA) levels in rats and inhibit 
iron-mediated lipid peroxidation in rat liver microsomes (Huh, 1994).  MDA is a thiobarbituric acid 
reactive substance (TBAR) formed as a byproduct of lipid peroxidation.  Iron is well known to be 
involved in the initiation and/or progression of lipid peroxidation in the liver, particularly through 
the Fenton reaction resulting in the production of the free radical and powerful oxidant, the 
hydroxyl radical.  A study by Huh (1994) showed a pronounced sex difference in lipid peroxide 
levels in rats, with male rats exhibiting a greater level of lipid peroxides than female rats.  Literature 
has also suggested a synergistic interaction between 17β-Estradiol and Interleukin-6 (Il-6), an 
inflammatory cytokine that aids in stimulating an immune response.  Il-6 promotes sex bias in 
experimental drug-induced liver injury (DILI) by reducing regulatory T cells (Tregs) (Cho, 2013).  
Additional studies need to be performed to better understand how 17β-Estradiol may contribute to 
sex-related differences in susceptibility to APAP-induced hepatotoxicity. 
The present study demonstrates that Nrf2 is not responsible for the resistance of female 
mice to APAP-induced hepatotoxicity and indicates that other mechanisms must contribute to this 
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sex difference.  Future studies will allow for a better understanding of the different mechanisms that 
may contribute to the differential susceptibility of male and female mice to APAP-induced 
hepatotoxicity, and the identification of new gene targets involved in APAP hepatotoxicity will 
create opportunities for the development of new therapeutic interventions to aid in the prevention 
and treatment of drug-induced liver injury. 
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Chapter Three 
 
Summary 
 
Sex is known to play an important role in drug absorption, metabolism, distribution, and 
excretion (Morris, 2003, Tanaka, 1999).  It is, therefore, imperative when studying drug toxicity to 
understand the differences in susceptibility of drugs between males and females.  In turn, clinicians 
can better adjust dosages of pharmaceuticals to compensate for any differences between sexes.  The 
work presented in this thesis explores the role of Nrf2, a nuclear transcription factor that positively 
regulates the expression and activity of cytoprotective genes during periods of oxidative stress, in the 
differential susceptibility of males and females to APAP-induced hepatotoxicity.  This work will aid 
in the progression of identifying new potential gene targets involved in APAP hepatotoxicity, 
allowing for future opportunities to develop new therapeutic interventions aiding in the prevention 
and treatment of drug-induced liver injury. 
Previous work has shown differences in susceptibility of male and female mice to APAP-
induced hepatotoxicity, where female mice show greater resistance to APAP-induced hepatotoxicity 
than their male counterparts, however, the mechanism(s) underlying these sex differences remains 
unknown.  Current literature reports sex differences in various genes involved in cytoprotection 
(Dai, 2006, McConnachie, 2007, Masubuchi, 2011, Sheng, 2013).  Many of these genes are more 
highly expressed in females than males and are transcriptionally regulated by Nrf2.  Therefore, the 
experiments in Chapter 2 examine mRNA and protein expression of Nrf2 and Nrf2-dependent 
genes between male and female mice.  The mouse closely resembles the type of response seen in 
humans intoxicated with APAP in terms of susceptibility to hepatotoxicity and the sequence and 
timing of events in hepatocyte injury and recovery.  Additionally, the availability of genetically-
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modified mice to explore mechanisms involved in APAP-induced hepatotoxicity, specifically with 
respect to Nrf2, is further justification for using a mouse model for these studies. 
It was demonstrated in Chapter 2 that Nrf2 is not responsible for the differential 
susceptibility of male and female mice to APAP-induced hepatotoxicity.  Lower Nrf2 mRNA and 
protein expression was observed in livers of naïve WT female mice as well as overnight-fasted WT 
female mice following vehicle- or APAP-treatment than in livers of male mice.  Most notably, while 
ALT activity was significantly elevated in both WT and Nrf2-null male mice following APAP 
administration, no increases in ALT were observed in either genotype of female mice.  Interestingly, 
hepatic mRNA levels of Nqo1 and Mrp4 were consistently higher in naïve wild-type, overnight-
fasted wild-type, and Nrf2-null females than males.  This finding suggests that other factors 
differentially expressed in male and female mice with greater expression in females than males may 
regulate the transcription of these two genes, thereby resulting in greater resistance of female than 
male mice to APAP-induced hepatotoxicity.  Future studies, however, are needed to better 
understand the sex-dependent susceptibility of mice to APAP hepatotoxicity. 
The experiments in Chapter 2 were designed to explore the sex differences in the role of 
various gene targets involved in APAP-induced hepatotoxicity in mice.  The results show that other 
factors, rather than Nrf2 are responsible for the difference in susceptibility of male and female mice 
to APAP-induced hepatotoxicity.  The question remains then, if Nrf2 is not responsible for this sex 
difference, what is?  As mentioned previously, the basal and APAP-inducible mRNA expression 
levels of Nqo1 and Mrp4 were consistently higher in female than male livers.  While the 
transcriptional activity of these genes is known to be regulated by Nrf2, other transcriptional 
regulators of these genes are known (Aleksunes, 2012).  Future in silico studies examining the 
promoter regions of these genes may aid in the identification of new regulatory sequences associated 
with transcription factors differentially expressed between males and females.  Further 
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understanding of the mechanism(s) contributing to the differential susceptibility of males and 
females to APAP hepatotoxicity will allow for the identification of new drug targets, thereby 
improving the development of new therapeutics targeting the treatment and prevention of drug-
induced liver injury. 
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